Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.20−0.15 (-42.59%)
Close on Nov 13, 2026Market cap $906.90KP/E –Yield –
Oragenics total assets
Total assets on the balance sheet at the end of each period.
Oragenics's total assets was $3.28M at Sep 30, 2026. For fiscal 2025 it was $10.07M, up 583.7% from the year before. Over ten years it grew 5.7% a year on average. The highest annual figure on record is $28.23M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.07M | +583.7% |
| FY2024 | Dec 31, 2024 | $1.47M | -70.4% |
| FY2023 | Dec 31, 2023 | $4.97M | -66.3% |
| FY2022 | Dec 31, 2022 | $14.76M | -47.7% |
| FY2021 | Dec 31, 2021 | $28.23M | +51.1% |
| FY2020 | Dec 31, 2020 | $18.68M | -5.4% |
| FY2019 | Dec 31, 2019 | $19.75M | -10.4% |
| FY2018 | Dec 31, 2018 | $22.05M | +205.6% |
| FY2017 | Dec 31, 2017 | $7.21M | +67.4% |
| FY2016 | Dec 31, 2016 | $4.31M | -25.4% |
| FY2015 | Dec 31, 2015 | $5.78M | -48.1% |
| FY2014 | Dec 31, 2014 | $11.13M | -33.9% |
| FY2013 | Dec 31, 2013 | $16.83M | +60.5% |
| FY2012 | Dec 31, 2012 | $10.49M | +727.8% |
| FY2011 | Dec 31, 2011 | $1.27M | -26.7% |
| FY2010 | Dec 31, 2010 | $1.73M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.28M | -74.2% |
| Q2 FY2026 | Jun 30, 2026 | $5.49M | +156.7% |
| Q1 FY2026 | Mar 31, 2026 | $7.49M | +93.6% |
| Q4 FY2025 | Dec 31, 2025 | $10.07M | +583.7% |
| Q3 FY2025 | Sep 30, 2025 | $12.71M | +144.1% |
| Q2 FY2025 | Jun 30, 2025 | $2.14M | -21.0% |
| Q1 FY2025 | Mar 31, 2025 | $3.87M | +9.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.47M | -70.4% |
| Q3 FY2024 | Sep 30, 2024 | $5.20M | -34.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.71M | -68.0% |
| Q1 FY2024 | Mar 31, 2024 | $3.53M | -70.9% |
| Q4 FY2023 | Dec 31, 2023 | $4.97M | -66.3% |
| Q3 FY2023 | Sep 30, 2023 | $7.90M | -53.7% |
| Q2 FY2023 | Jun 30, 2023 | $8.46M | -58.4% |
| Q1 FY2023 | Mar 31, 2023 | $12.13M | -48.7% |
| Q4 FY2022 | Dec 31, 2022 | $14.76M | -47.7% |
| Q3 FY2022 | Sep 30, 2022 | $17.05M | -45.2% |
| Q2 FY2022 | Jun 30, 2022 | $20.35M | -42.3% |
| Q1 FY2022 | Mar 31, 2022 | $23.65M | -36.7% |
| Q4 FY2021 | Dec 31, 2021 | $28.23M | +51.1% |
| Q3 FY2021 | Sep 30, 2021 | $31.09M | +175.6% |
| Q2 FY2021 | Jun 30, 2021 | $35.25M | +228.4% |
| Q1 FY2021 | Mar 31, 2021 | $37.37M | +140.1% |
| Q4 FY2020 | Dec 31, 2020 | $18.68M | -5.4% |
| Q3 FY2020 | Sep 30, 2020 | $11.28M | -52.3% |
| Q2 FY2020 | Jun 30, 2020 | $10.73M | -60.2% |
| Q1 FY2020 | Mar 31, 2020 | $15.56M | -50.3% |
| Q4 FY2019 | Dec 31, 2019 | $19.75M | -10.4% |
| Q3 FY2019 | Sep 30, 2019 | $23.65M | +52.2% |
| Q2 FY2019 | Jun 30, 2019 | $26.93M | +417.1% |
| Q1 FY2019 | Mar 31, 2019 | $31.31M | +469.8% |
| Q4 FY2018 | Dec 31, 2018 | $22.05M | +205.6% |
| Q3 FY2018 | Sep 30, 2018 | $15.54M | +202.5% |
| Q2 FY2018 | Jun 30, 2018 | $5.21M | +13.8% |
| Q1 FY2018 | Mar 31, 2018 | $5.49M | +133.7% |
| Q4 FY2017 | Dec 31, 2017 | $7.21M | +67.4% |
| Q3 FY2017 | Sep 30, 2017 | $5.14M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.58M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.35M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.31M | – |
See a number that looks wrong?